Promises and challenges of pneumococcal conjugate vaccines for the developing world.
Grijalva
Carlos G
CG
Edwards
Kathryn M
KM
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002353:Carrier State; D002675:Child, Preschool; D003906:Developing Countries; D024881:Drug Resistance, Bacterial; D005714:Gambia / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000382:microbiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000191:economics; D012307:Risk Factors; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D018074:Vaccines, Conjugate
D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate